Loading
Latest filing published 12 May 2026 for 팜젠사이언스. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
한의상 is a declared insider of 팜젠사이언스 (chief executive), with filings sourced from DART (FSS). We count 34 filings; the first trade dates from 3 December 2021 and the latest from 11 May 2026.
On the open market, the record shows 32 purchases and 1 sale. The totals exclude 33 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at no purchases and 1 sale.
None of the 31 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The latest filing, published on 12 May 2026, reports an open-market sale in 팜젠사이언스. The most recent open-market purchase was published on 18 December 2025, 304 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 1 day. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 34 declarations